Skip to main content
Premium Trial:

Request an Annual Quote

Metabolomics Society Signs Australian, New Zealand Partnership

NEW YORK (GenomeWeb News) – The Metabolomics Society has agreed to a formal plan with the Australia and New Zealand Metabolomics Network, or ANZMN, to increase their cooperation and share knowledge with the goal of promoting the development, adoption, and application of metabolomics in scientific research.

The society, an international nonprofit organization, said recently that the new memorandum of agreement it has inked with ANZMN will enable the partners to work more closely on their common goals of advancing and promoting the use of metabolomics in research in the New Zealand and Australian regions.

The society said that partnerships such as this one will make both groups more effective, will promote public awareness of their resources, such as publications, services, and information, and will enable them to communicate to plan conferences, workshops, and training programs for scientists from across the biological sciences.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.